Edition:
India

Zafgen Inc (ZFGN.OQ)

ZFGN.OQ on NASDAQ Stock Exchange Global Select Market

3.76USD
1:56am IST
Change (% chg)

$0.03 (+0.80%)
Prev Close
$3.73
Open
$3.72
Day's High
$3.79
Day's Low
$3.61
Volume
7,795
Avg. Vol
23,455
52-wk High
$5.43
52-wk Low
$3.11

Select another date:

Wed, Nov 8 2017

BRIEF-Zafgen reports Q3 loss per share $0.46

* Q3 earnings per share view $-0.58 -- Thomson Reuters I/B/E/S

BRIEF-Zafgen appoints Jeffrey Hatfield as CEO

* Zafgen appoints Jeffrey Hatfield as Chief Executive Officer; Thomas Hughes, Ph.D. to continue as president, appointed chief scientific officer

BRIEF-Zafgen initiates Phase 2 clinical trial for ZGN-1061

* Zafgen initiates Phase 2 clinical trial for ZGN-1061 in patients with Type 2 diabetes Source text for Eikon: Further company coverage:

BRIEF-Zafgen Inc files for a potential mixed shelf offering of up to $150 mln

* Zafgen Inc files for a potential mixed shelf offering of up to $150 million - SEC filing Source text: (http://bit.ly/2vkwJqL) Further company coverage:

BRIEF-Zafgen Q2 loss per share $0.49

* Q2 earnings per share view $-0.52 -- Thomson Reuters I/B/E/S Source text for Eikon: Further company coverage:

BRIEF-Zafgen preclinical abstract will present results for zgn-1061 on glycemic control, weight loss and safety profile

* Zafgen to present two late-breaking abstracts for zgn-1061 at the american diabetes association 77th scientific sessions

Select another date: